Gilder Gagnon Howe & Co’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$747K Buy
28,902
+1,410
+5% +$36.4K 0.01% 209
2025
Q1
$280K Buy
+27,492
New +$280K ﹤0.01% 224